Agent used as pre-treatmenta
|
MIC/MBC (μg/mL)
|
Final concentration (μg/mL)
|
PAEb (h)
|
PAEPc (h)
|
Snov-PAEPd (h)
|
---|
0
|
1
|
2
|
---|
GEN
|
2/2
|
4
|
0.75 + 0,01
|
0
|
< 0.25
|
< 0.25
|
< 0.25
|
CIP
|
2/2
|
4
|
1.5 + 0,06
|
0
|
< 0.25
|
< 0.25
|
< 0.25
|
IPM
|
2/2
|
4
|
0
|
0
|
< 0.25
|
< 0.25
|
< 0.25
|
PMB
|
1/1
|
2
|
0.1 + 0,02
|
2–3
|
3.2 + 0.06
|
2.7 + 0.05
|
1.1 + 0.03
|
- a GEN, gentamicin; CIP, ciprofloxacin; IPM, imipenem; PMB, polymyxin B
- b Post-antibiotic effect assessed by turdidimetry (Bioscreen)
- c Duration of Post-Antibiotic Effect-associated Permeabilization. PAEs y S-PAEPs values are the average of two independent experiments performed in triplicate. Differences were analyzed by Kruskal–Wallis test followed by Mann–Whitney’s U test
- d Score of Post-Antibiotic Effect-associated Permeabilization. Delay in h caused by exposure to a sub-MIC concentration of novobiocin (1/8 x MIC) added at the indicated time (0 h, 1 h, 2 h) after the beginning of growth in peptide-free medium. S-PAEP was assessed by turdidimetry (Bioscreen)